The Medical University of Graz is a public medical university located in Graz, Austria.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Medical University of Graz, Pulmonology
During the past decade, Medical University of Graz, Pulmonology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab.
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Epidemiological Characteristics and Outcomes of Patients Admitted to Kenyan Critical Care Units (EPOK).
2021-01-01
2022-09-01
Recruiting
4,000
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Medical University of Graz, Pulmonology"
#1 collaborator was "Actelion" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Medical University of Graz, Pulmonology
According to Clinical.Site data, the most researched conditions in "Medical University of Graz, Pulmonology" are
"Pulmonary Hypertension" (3 trials), "Systemic Sclerosis" (2 trials), "Myelodysplastic Syndromes" (1 trials), "Myeloproliferative Disorder" (1 trials) and "Myeloproliferative Disorders" (1 trials). Many other conditions were trialed in "Medical University of Graz, Pulmonology" in a lesser frequency.
Clinical Trials Intervention Types at Medical University of Graz, Pulmonology
Most popular intervention types in "Medical University of Graz, Pulmonology" are "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bosentan" (1 trials), "Echocardiography, spiroergometry, cardiac catheterization" (1 trials) and "echocardiography, right heart catheterisation" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medical University of Graz, Pulmonology
The vast majority of trials in "Medical University of Graz, Pulmonology" are
4 trials for "All" genders.
Clinical Trials Status at Medical University of Graz, Pulmonology
Currently, there are NaN active trials in "Medical University of Graz, Pulmonology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Medical University of Graz, Pulmonology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Medical University of Graz, Pulmonology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".